Mediolanum International Funds Ltd
Position in NBIX — Neurocrine Biosciences Inc
CIK 2022028
DUBLIN 1, L2
Position in NBIX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$4,094,342
+$2,764,559 QoQ
Shares Held
24,293
+140.7% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#232
of 768 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Mediolanum International Funds Ltd holds $17,407,960 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (23.5% of the industry book) .
All Filings in NBIX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,094,342 | 24,293 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,329,783 | 10,094 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $7,290,912 | 51,406 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $473,642 | 3,374 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,411,362 | 19,185 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,383,389 | 57,716 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $7,690,956 | 56,344 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $6,901,908 | 59,902 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $6,345,623 | 46,093 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,352,167 | 9,804 | Shares | Sole | 2024-05-03 | |
| No filing history on record for this holder in this stock. | ||||||